Kelli McGillicuddy

Standards & Governance Global Lead for Biosimilars Business Unit (BBU) at Biogen

Kelli McGillicuddy is the Standards & Governance Global Lead for Biogen’s Biosimilars Business. With over 12+ years of professional experience in life sciences, she previously worked at Genzyme Corporation before joining Biogen in 2013. During the past few years, Kelli launched the Standards & Governance role for Biogen’s International Partner Markets in Switzerland and Biogen’s Australia & New Zealand affiliate. In both roles, Kelli served as a strategic partner to the business providing support, process improvement creation and initiatives, and promoted an ethical, compliant, and accountable culture. Kelli has extensive business and cross-cultural experience in US, EU, Middle East, North Africa, LATAM and APAC regions where she empowers senior business leaders and teammates. Most recently, Kelli supported the launch of Biogen’s new Biosimilars business in the US.